Mounjaro Nausea and Vomiting: Causes, Management, and What to Expect

Mounjaro (tirzepatide) is a groundbreaking prescription medication for managing type 2 diabetes and supporting weight loss. However, it commonly causes gastrointestinal side effects, especially nausea and vomiting, during the initial treatment phase. This comprehensive guide helps patients in Islamabad and worldwide understand these reactions, learn effective management strategies, and know what to expect for a smoother treatment journey.

Understanding Mounjaro: How It Works and Why Side Effects Occur

What is Mounjaro?

Mounjaro is a dual GLP-1 and GIP receptor agonist, a novel class of drugs that targets multiple pathways to improve blood sugar control and promote satiety. It is administered via weekly injection and is prescribed for adults with type 2 diabetes, often leading to significant weight loss as a secondary benefit.

The Mechanism Behind Mounjaro’s Action

Mounjaro mimics natural hormones to: